Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Aspirin 81mg
DRUG
4 trials
Sponsors
NYU Langone Health
, Eastern Virginia Medical School
, Johns Hopkins University
, University of Pennsylvania
Conditions
Body Weight
Pre-Eclampsia
Pregnancy Loss
Pulmonary Disease, Chronic Obstructive
Phase 3
Trial to Determine Effective Aspirin Dose in COPD
Recruiting
NCT05265299
Johns Hopkins University
Pulmonary Disease, Chronic Obstructive
Start: 2023-05-16
End: 2026-12-01
Target: 48
Updated: 2026-03-16
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
Recruiting
NCT06408181
University of Pennsylvania
Pre-Eclampsia, Pregnancy Loss
Start: 2024-06-12
End: 2029-06-01
Target: 1150
Updated: 2026-01-20
Phase 4
Body Weight, Aspirin Dose and Pro-resolving Mediators
Completed
NCT04697719
NYU Langone Health
Body Weight
Start: 2021-11-04
End: 2025-01-29
Updated: 2026-03-09
Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension
NCT04908982
Eastern Virginia Medical School
Pre-Eclampsia
Start: 2021-05-28
End: 2023-05-31
Target: 60
Updated: 2021-06-28
Related Papers
A randomized, placebo-controlled crossover trial to assess the influence of body weight on aspirin-triggered specialized pro-resolving mediators: protocol for the discover study
International Journal of Clinical Trials
2024-01-24